RESUMO
N disponible (AU)
Assuntos
Idoso , Masculino , Humanos , Diretivas Antecipadas , Hospedeiro Imunocomprometido , Estado Terminal , Autonomia Pessoal , Scedosporium , Tomada de Decisões , Hemorragia Subaracnóidea , Ticlopidina , Leucemia Mielogênica Crônica BCR-ABL Positiva , Evolução Fatal , Inibidores da Agregação Plaquetária , Qualidade de Vida , Planejamento Antecipado de Cuidados , Crise Blástica , Protocolos de Quimioterapia Combinada Antineoplásica , Micetoma , SepseRESUMO
No disponible
Assuntos
Idoso , Feminino , Humanos , Dor Abdominal , Sepse , Mucosa , Transtornos da Pigmentação , Fístula Biliar , Infecções por Clostridium , Fístula Intestinal , HemóliseAssuntos
Fístula Biliar/diagnóstico , Infecções por Clostridium/diagnóstico , Fístula Intestinal/diagnóstico , Sepse/diagnóstico , Dor Abdominal/etiologia , Idoso , Fístula Biliar/complicações , Infecções por Clostridium/complicações , Feminino , Hemólise , Humanos , Fístula Intestinal/complicações , Mucosa , Transtornos da Pigmentação/etiologia , Sepse/complicaçõesRESUMO
No disponible
Assuntos
Gravidez , Feminino , Humanos , Síndrome HELLP , Pré-Eclâmpsia , Transtornos PuerperaisRESUMO
Primary non-Hodgkin lymphoma (NHL) of the maxillary sinus is an infrequent neoplasm that represents about 8% of all malignancies in this area. A review was made of 74 patients diagnosed as malignancy of the maxillary sinus in a 20-year period. Five cases of primary extraganglionar NHL of the maxillary sinus were found. We describe all the cases and their extension in detail. The clinical manifestations, treatment, and long-term survival of these patients are discussed.
Assuntos
Linfoma não Hodgkin/diagnóstico , Linfoma não Hodgkin/terapia , Seio Maxilar/diagnóstico por imagem , Neoplasias dos Seios Paranasais/diagnóstico , Neoplasias dos Seios Paranasais/terapia , Adolescente , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Estudos Retrospectivos , Tomografia Computadorizada por Raios XRESUMO
A 47-old male with accelerated-phase chronic myelogenous leukaemia is presented. In spite of a good response to hydroxyurea and interferon treatment, the patient developed multiple foci of granulocytic sarcoma as a special form of blastic crisis. A review was carried out of the different aspects of this entity, stress being laid on the diagnostic characteristics and the current therapeutic approach in such cases.
Assuntos
Crise Blástica/patologia , Neoplasias Ósseas/patologia , Leucemia Mieloide de Fase Acelerada/patologia , Crise Blástica/tratamento farmacológico , Crise Blástica/radioterapia , Neoplasias Ósseas/tratamento farmacológico , Neoplasias Ósseas/radioterapia , Evolução Fatal , Humanos , Leucemia Mieloide de Fase Acelerada/tratamento farmacológico , Linfonodos/patologia , Masculino , Pessoa de Meia-IdadeAssuntos
Linfoma não Hodgkin/epidemiologia , Adolescente , Adulto , Distribuição por Idade , Idoso , Criança , Comorbidade , Feminino , Humanos , Hospedeiro Imunocomprometido , Linfoma não Hodgkin/etiologia , Masculino , Pessoa de Meia-Idade , Neoplasias Induzidas por Radiação/epidemiologia , Ocupações , Oncogenes , Fatores de Risco , Distribuição por Sexo , Fatores Socioeconômicos , Infecções Tumorais por Vírus/epidemiologiaAssuntos
Infecções por Bacillaceae/complicações , Bacillus cereus , Hemólise , Leucemia Monocítica Aguda/complicações , Complicações Infecciosas na Gravidez , Complicações Neoplásicas na Gravidez , Sepse/complicações , Adulto , Evolução Fatal , Feminino , Humanos , Hospedeiro Imunocomprometido , Neutropenia/complicações , Gravidez , Sepse/microbiologiaAssuntos
Doenças Autoimunes , Púrpura Trombocitopênica Idiopática , Adulto , Autoanticorpos/análise , Autoanticorpos/imunologia , Doenças Autoimunes/diagnóstico , Doenças Autoimunes/epidemiologia , Doenças Autoimunes/etiologia , Doenças Autoimunes/terapia , Subpopulações de Linfócitos B/imunologia , Criança , Terapia Combinada , Feminino , Humanos , Imunoglobulinas Intravenosas/uso terapêutico , Imunossupressores/uso terapêutico , Incidência , Recém-Nascido , Masculino , Gravidez , Complicações na Gravidez/terapia , Púrpura Trombocitopênica Idiopática/diagnóstico , Púrpura Trombocitopênica Idiopática/epidemiologia , Púrpura Trombocitopênica Idiopática/etiologia , Púrpura Trombocitopênica Idiopática/imunologia , Púrpura Trombocitopênica Idiopática/terapia , Remissão Espontânea , Fatores de Risco , Esplenectomia , Trombocitopenia/congênito , Viroses/complicaçõesRESUMO
PURPOSE: To assess the clinico-biological features appearing in 307 patients with non-Hodgkin's lymphomas (NHL). PATIENTS AND METHODS: The clinical records of 338 patients diagnosed of NHL between January 1975 and December 1988 were revised in retrospect. All cases with histologic diagnosis of NHL aged over 14 years were included, and classified in accordance with the Working Formulation criteria. The following data were analysed: age, sex, first complaints, time elapsed since onset, histologic type, number of sites involved, bulky disease, anaemia, thrombocytopenia, LDH, stage, type of treatment and initial response, survival, and cause of death. The statistical evaluation was performed by actuarial analysis (Kaplan and Meier) and comparison (log-rank test) of survival. RESULTS: According to the three categories of the malignancies, the NHL were distributed into low-grade (37.8%), intermediate (36.1%) and high-grade (26.9%). The mean age of the series was 56.6 years and the M/F ratio was 1.3. Lymph node enlargement was the commonest finding; 36.4% of the patients had symptoms related with the disease, and 26.7% had bulky disease. Anaemia was present in 37.7% of the cases and thrombocytopenia in 14.3%, with similar distribution among the three grades. High LDH levels were found in 44% of the patients. At diagnosis, 85% of the patients were in advanced stages (III+IV) already. Complete response was attained in 51.1% of the cases, with median survival of 48 months. CONCLUSIONS: The clinico-evolutive data found here are similar to other reports in the literature. In one-half of the patients the cause of the first visit is lymph node enlargement. Complete remission is achieved by one out of two patients, this figure being similar for each of the histologic groups. The Working Formulation is useful in determining the different prognostic groups with respect to survival.
Assuntos
Linfoma não Hodgkin/patologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores Tumorais/sangue , Causas de Morte , Feminino , Humanos , Incidência , L-Lactato Desidrogenase/sangue , Tábuas de Vida , Linfoma não Hodgkin/enzimologia , Linfoma não Hodgkin/epidemiologia , Masculino , Pessoa de Meia-Idade , Proteínas de Neoplasias/sangue , Estudos Retrospectivos , Análise de SobrevidaRESUMO
PURPOSE: To analyse different clinico-biologic data in order to assess their prognostic value in non-Hodgkin's lymphoma (NHL) patients. MATERIAL AND METHODS: The series comprises 307 patients with NHL diagnosed and treated between 1975 and 1988. The histopathologic diagnosis was revised in accordance with the working formulation system, three prognostic groups being thus considered: low-grade (LGL), intermediate-grade (IGL) and high-grade (HGL) lymphomas. Age, sex, clinical course prior to diagnosis, presence of B symptoms, histologic type, number of lymph-node areas involved, bulky disease, anaemia, thrombocytopenia, LDH, stage and response to therapy were all evaluated for the study. Survival curves were drawn with the Kaplan-Meier method, and the log-rank test was used for comparison of median survival. Whenever the univariate analysis achieved statistical significance, a multivariate analysis was performed by means of a multiple correlation and regression study in accordance with the Cox's model, in which the variables were expressed in a binary model. RESULTS: The following 8 values were found significant in the univariate study of low-grade lymphomas: age, number of involved areas, bulky disease anaemia, thrombocytopenia, LDH, stage, and initial response to treatment. In intermediate-grade lymphomas, the significant findings were age, number of affected areas, bulky disease, thrombocytopenia, LDH, stage, and initial response. For high-grade lymphomas, number of affected areas, thrombocytopenia, LDH, stage and initial response were found statistically significant. Although no significant differences were found for survival within each of the three grades, such differences were significant between them. In the multivariate analysis, age was significant only in the LGL (p < 0.0001) in IGL, age (p < 0.07) and initial response to therapy (p < 0.0001) achieved significant value, and in HGL, stage (p < 0.02) and initial response to treatment (p < 0.0001) attained significance. CONCLUSIONS: The univariate analysis provides various prognostic factors of statistically significance, as reported in the literature, but these after the multivariate analysis was applied, were reduced to age, stage and initial response to treatment.